Article
Comparative diagnostic performance of the new chromatographic Affimer<sup>®</sup>-based rapid antigen detection against SARS-CoV-2 and other standard antigen tests for COVID-19 in a clinical setting
2022-01-26
Abstract excerpt
The availability of accurate and rapid diagnostic tools for COVID-19 is essential for tackling the ongoing pandemic. In this context, researchers in the UK have started testing a new Lateral Flow Device (LFD) based on proprietary Biotinylated anti SARS-CoV-2 S1 Affimer® technology that binds to the SARS-CoV2-S1 protein in anterior nasal swab samples, generating an ultra-sensitive method for detection. This interna...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aa37476a-aed3-5d66-a91a-036226c0c0d8
- DOI
- 10.1101/2022.01.18.22269401
